Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Variant between CPT1B and CHKB associated with susceptibility to narcolepsy


Narcolepsy (hypocretin deficiency), a sleep disorder characterized by sleepiness, cataplexy and rapid eye movement (REM) sleep abnormalities, is tightly associated with HLA-DRB1*1501 (M17378) and HLA-DQB1*0602 (M20432). Susceptibility genes other than those in the HLA region are also likely involved. We conducted a genome-wide association study using 500K SNP microarrays in 222 Japanese individuals with narcolepsy and 389 Japanese controls, with replication of top hits in 159 Japanese individuals with narcolepsy and 190 Japanese controls, followed by the testing of 424 Koreans, 785 individuals of European descent and 184 African Americans. rs5770917, a SNP located between CPT1B and CHKB, was associated with narcolepsy in Japanese (rs5770917[C], odds ratio (OR) = 1.79, combined P = 4.4 × 10−7) and other ancestry groups (OR = 1.40, P = 0.02). Real-time quantitative PCR assays in white blood cells indicated decreased CPT1B and CHKB expression in subjects with the C allele, suggesting that a genetic variant regulating CPT1B or CHKB expression is associated with narcolepsy. Either of these genes is a plausible candidate, as CPT1B regulates β-oxidation, a pathway involved in regulating theta frequency during REM sleep, and CHKB is an enzyme involved in the metabolism of choline, a precursor of the REM- and wake-regulating neurotransmitter acetylcholine.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Genome-wide association results for 222 Japanese narcoleptic individuals and 389 Japanese controls.
Figure 2: Pairwise linkage disequilibrium (D′) diagram for CPT1B and CHKB.
Figure 3: Expression analysis of CPT1B and CHKB.


  1. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology 50, S16–S22 (1998).

    Article  CAS  Google Scholar 

  2. Overeem, S., Mignot, E., van Dijk, J.G. & Lammers, G.J. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J. Clin. Neurophysiol. 18, 78–105 (2001).

    Article  CAS  Google Scholar 

  3. Juji, T., Satake, M., Honda, Y. & Doi, Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24, 316–319 (1984).

    Article  CAS  Google Scholar 

  4. Langdon, N., Welsh, K.I., van Dam, M., Vaughan, R.W. & Parkes, D. Genetic markers in narcolepsy. Lancet 2, 1178–1180 (1984).

    Article  CAS  Google Scholar 

  5. Mignot, E. et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68, 686–699 (2001).

    Article  CAS  Google Scholar 

  6. Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376 (1999).

    Article  CAS  Google Scholar 

  7. Chemelli, R.M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437–451 (1999).

    Article  CAS  Google Scholar 

  8. Nishino, S., Ripley, B., Overeem, S., Lammers, G.J. & Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40 (2000).

    Article  CAS  Google Scholar 

  9. Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991–997 (2000).

    Article  CAS  Google Scholar 

  10. Hungs, M., Lin, L., Okun, M. & Mignot, E. Polymorphisms in the vicinity of the hypocretin/orexin are not associated with human narcolepsy. Neurology 57, 1893–1895 (2001).

    Article  CAS  Google Scholar 

  11. Olafsdottir, B.R. et al. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. Neurology 57, 1896–1899 (2001).

    Article  CAS  Google Scholar 

  12. Gencik, M. et al. A prepro-orexin gene polymorphism is associated with narcolepsy. Neurology 56, 115–117 (2001).

    Article  CAS  Google Scholar 

  13. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96, 434–442 (2004).

    Article  Google Scholar 

  14. Fleiss, J.L. The statistical basis of meta-analysis. Stat. Methods Med. Res. 2, 121–145 (1993).

    Article  CAS  Google Scholar 

  15. McGarry, J.D. & Brown, N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244, 1–14 (1997).

    Article  CAS  Google Scholar 

  16. Yoshida, G. et al. Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine-deficient mice. Neurosci. Res. 55, 78–86 (2006).

    Article  CAS  Google Scholar 

  17. Hara, J. et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345–354 (2001).

    Article  CAS  Google Scholar 

  18. Kuwajima, M. et al. Reduced carnitine level causes death from hypoglycemia: possible involvement of suppression of hypothalamic orexin expression during weaning period. Endocr. J. 54, 911–925 (2007).

    Article  CAS  Google Scholar 

  19. Tafti, M. et al. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat. Genet. 34, 320–325 (2003).

    Article  CAS  Google Scholar 

  20. Liu, J. et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. USA 99, 2356–2361 (2002).

    Article  CAS  Google Scholar 

  21. Rao, K.V. & Qureshi, I.A. Decompensation of hepatic and cerebral acyl-CoA metabolism in BALB/cByJ mice by chronic riboflavin deficiency: restoration by acetyl-L-carnitine. Can. J. Physiol. Pharmacol. 75, 423–430 (1997).

    CAS  PubMed  Google Scholar 

  22. Aoyama, C., Liao, H. & Ishidate, K. Structure and function of choline kinase isoforms in mammalian cells. Prog. Lipid Res. 43, 266–281 (2004).

    Article  CAS  Google Scholar 

  23. Kent, C. CTP:phosphocholine cytidylyltransferase. Biochim. Biophys. Acta 1348, 79–90 (1997).

    Article  CAS  Google Scholar 

  24. Zweigner, J. et al. Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain. J. Exp. Med. 200, 99–106 (2004).

    Article  CAS  Google Scholar 

  25. Fioravanti, M. & Yanagi, M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst. Rev. 2, CD000269 (2005).

    Google Scholar 

  26. Dixon, C.E., Ma, X. & Marion, D.W. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma 14, 161–169 (1997).

    Article  CAS  Google Scholar 

  27. Nishino, S. & Mignot, E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52, 27–78 (1997).

    Article  CAS  Google Scholar 

  28. Mignot, E. & Nishino, S. Emerging therapies in narcolepsy-cataplexy. Sleep 28, 754–763 (2005).

    Article  Google Scholar 

  29. Nishida, N., Tanabe, T., Takasu, M., Suyama, A. & Tokunaga, K. Further development of multiplex single nucleotide polymorphism typing method, the DigiTag2 assay. Anal. Biochem. 364, 78–85 (2007).

    Article  CAS  Google Scholar 

  30. Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).

    Article  Google Scholar 

Download references


We would like to express our sincere thanks to the study participants. This study was supported by Grants-in-Aid for Scientific Research on Priority Areas “Comprehensive Genomics” and “Applied Genomics” from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for JSPS fellows, and US National Institutes of Health grant NS 23724 to E. Mignot, a Howard Hughes Investigator.

Author information

Authors and Affiliations



Study design: T.M., M.K., E.M. and K.T.; sample collection: T.M., M.K., L.L., S.-C.H., J.F., Y.-K.S., J.-H.J., Y.O., S.T., M.H., Y.H. and E.M.; genotyping: T.M., M.K., N.N., M.S., L.L., J.F., E.M. and K.T.; statistical analysis: T.M., J.O., R.K., A.F., S.M., T.S., M.H., E.M. and K.T.; real-time quantitative RT-PCR: T.M. and M.H.; manuscript writing: T.M., M.K., E.M. and K.T.

Corresponding author

Correspondence to Katsushi Tokunaga.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1–4, Supplementary Figures 1 and 2 (PDF 67 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Miyagawa, T., Kawashima, M., Nishida, N. et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 40, 1324–1328 (2008).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing